The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 2 de enero del 2002
Oct 25, 2014 - A novel gene therapy for glioblastoma multiforme utilizing a combination of adenoviral vectors and the drug ganciclovir is nearing clinical trial with the discovery of a biomarker to gauge tumor response to the treatment, according to a study reported in the July 1 issue of Clinical Cancer Research.
Oct 25, 2014
Aug 5, 2010